retatrutide phase 2 trial type 2 diabetes Reta clinical data & dosing β a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in 3 trials for metabolic health β targeting GLP-1, GIP π€ Adults with type 2
Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 21 - Aug 26






















